Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PERRIGO Co plcPRGO · Entity 4516 | EVP, Chief Medical Officer | April 05, 2024 | April 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PERRIGO Co plc
Report date April 05, 2024 · Filed April 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,210 |
Reported balance
After 2024-04-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-04-05 · Grant · Acquired 6,210 · Balance 6,210 F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 21,078 |
Reported balance
Holding disclosure · report date 2024-04-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 21,078 |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 194 | $53.17 | $10,314.98 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,814 Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 373 | $53.17 | $19,832.41 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,008 F2 · kind: Vesting of performance-based restricted stock units granted on June 6, 2017. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 639 | $53.17 | $33,975.63 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,635 Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,227 | $53.17 | $65,239.59 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 23:35 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | Not disclosed | Not disclosed | $3,157.00 |
DisclosureSEC source: 0001585364-20-000021 · wf-form4_158379692473657.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,157 Underlying: Ordinary Shares · 3,157 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 18:33 UTC | PERRIGO Co plc PRGO · Entity 4516 | SaleOrdinary Shares | 2,050 | $49.08 | $100,614.00 |
DisclosureSEC source: 0001585364-19-000110 · wf-form4_157367002331179.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,047 Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 19:40 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 5,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-19-000094 · wf-form4_157073639166597.xml · derivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,011 shares Expires 2019-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 19:40 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 2,606 | $51.94 | $135,355.64 |
DisclosureSEC source: 0001585364-19-000094 · wf-form4_157073639166597.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,098 Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 19:40 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 5,011 | $51.94 | $260,271.34 |
DisclosureSEC source: 0001585364-19-000094 · wf-form4_157073639166597.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on October 8, 2018. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 21:27 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 3,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001585364-19-000031 · wf-form4_155208043274019.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,679 Underlying: Ordinary Shares · 3,679 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 254 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-19-000025 · wf-form4_155138516521570.xml · derivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 254 shares Expires 2019-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · kind: Vesting of service-based restricted stock units granted on February 26, 2016. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 133 | $48.29 | $6,422.57 |
DisclosureSEC source: 0001585364-19-000025 · wf-form4_155138516521570.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,693 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 254 | $48.29 | $12,265.66 |
DisclosureSEC source: 0001585364-19-000025 · wf-form4_155138516521570.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on February 26, 2016. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 192 | $48.29 | $9,271.68 |
DisclosureSEC source: 0001585364-19-000025 · wf-form4_155138516521570.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,572 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 368 | $48.29 | $17,770.72 |
DisclosureSEC source: 0001585364-19-000025 · wf-form4_155138516521570.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,764 F1 · kind: Vesting of performance-based restricted stock units granted on February 26, 2016. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 21:02 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 5,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-18-000078 · wf-form4_153920531792545.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,011 Underlying: Ordinary Shares · 5,011 shares Expires 2019-10-08 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 23:49 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-18-000059 · wf-form4_153066173757886.xml · derivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 262 shares Expires 2018-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 23:49 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 137 | $72.91 | $9,988.67 |
DisclosureSEC source: 0001585364-18-000059 · wf-form4_153066173757886.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,396 Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 23:49 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 262 | $72.91 | $19,102.42 |
DisclosureSEC source: 0001585364-18-000059 · wf-form4_153066173757886.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on June 29, 2015. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:40 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantEmployee Stock Option Right to Buy · Derivative | 4,385 | $85.06 Strike: $85.06 | $372,988.10 |
DisclosureSEC source: 0001679915-18-000001 · wf-form4_152089802982131.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,385 Underlying: Ordinary Shares · 4,385 shares Expires 2028-03-08 F1 · derivative.exercise_date: Exercisable in 3 equal annual installments beginning 3/8/2019. Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-17-000144 · wf-form4_150353394485776.xml · derivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 147 shares Expires 2017-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on August 21, 2014. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 130 | $77.58 | $10,085.40 |
DisclosureSEC source: 0001585364-17-000144 · wf-form4_150353394485776.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,271 Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 251 | $77.58 | $19,472.58 |
DisclosureSEC source: 0001585364-17-000144 · wf-form4_150353394485776.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,401 F2 · kind: Vesting of performance-based restricted stock units granted on August 21, 2014. Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 77 | $77.58 | $5,973.66 |
DisclosureSEC source: 0001585364-17-000144 · wf-form4_150353394485776.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:19 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 147 | $77.58 | $11,404.26 |
DisclosureSEC source: 0001585364-17-000144 · wf-form4_150353394485776.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on August 21, 2014. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 19:41 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantEmployee Stock Option Right to Buy · Derivative | 3,282 | $70.34 Strike: $70.34 | $230,855.88 |
DisclosureSEC source: 0001585364-17-000095 · wf-form4_149695089882188.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Ordinary Shares · 3,282 shares Expires 2027-06-06 F1 · derivative.exercise_date: Exercisable in 3 equal annual installments beginning 6 June 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.